Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.62 |
| ▸ | NOD1 | Q9Y239 | 7/20 | 0.53 |
| ▸ | NMT2 | O60551 | 2/20 | 0.53 |
| ▸ | NMT1 | P30419 | 2/20 | 0.53 |
| ▸ | CTSL | P07711 | 1/20 | 0.52 |
| ▸ | FAAH | O00519 | 2/20 | 0.51 |
| ▸ | TLR2 | O60603 | 1/20 | 0.51 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.48 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.48 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.47 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.44 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28627441 | 1.00 | SLC6A5 (0.62) | SLC6A5NOD1NMT2NMT1CTSL | |
| SCHEMBL3121566 | 0.98 | SLC6A5 (0.60) | SLC6A5NOD1NMT2NMT1CTSL | |
| SCHEMBL29626727 | 0.96 | CTSL (0.58) | SLC6A5NOD1NMT2NMT1CTSL | |
| SCHEMBL29417579 | 0.93 | CTSL (0.58) | SLC6A5NOD1NMT2NMT1CTSL | |
| SCHEMBL5604836 | 0.92 | SLC6A5 (0.65) | SLC6A5NOD1NMT2NMT1CTSL | |
| SCHEMBL1280087 | 0.89 | SLC6A5 (0.58) | SLC6A5NOD1NMT2NMT1CTSL | |
| SCHEMBL352420 | 0.89 | SLC6A5 (0.58) | SLC6A5NOD1NMT2NMT1CTSL | |
| SCHEMBL1673194 | 0.89 | SLC6A5 (0.58) | SLC6A5NOD1NMT2NMT1CTSL | |
| SCHEMBL30399641 | 0.89 | SLC6A5 (0.58) | SLC6A5NOD1NMT2NMT1CTSL | |
| SCHEMBL30905802 | 0.89 | SLC6A5 (0.58) | SLC6A5NOD1NMT2NMT1CTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 289 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4281035-B1 | SKIN CARE COMPOSITION COMPRISING A COMBINATION OF PEPTIDES | PROCTER & GAMBLE (US) | 2025-07-09 | — | — | EP | claimed |
| US-20250152494-A1 | COSMETIC COMPOSITION CONTAINING RETINOID, EXTRACT OF CENTELLA ASIATICA AND A DIPEPTIDE | THE BOOTS COMPANY PLC (GB) | 2025-05-15 | — | — | US | claimed |
| EP-4479021-A1 | COSMETIC COMPOSITION CONTAINING RETINOID, EXTRACT OF CENTELLA ASIATICA AND A DIPEPTIDE | The Boots Company PLC (GB) | 2024-12-25 | — | — | EP | claimed |
| CN-119072299-A | Cosmetic composition containing retinoid, centella asiatica extract and dipeptide | 布茨公司 | 2024-12-03 | — | — | CN | claimed |
| US-11850299-B2 | Skin care composition and method of using the same | THE PROCTER & GAMBLE COMPANY (US) | 2023-12-26 | — | — | US | claimed |
| EP-4281035-A1 | SKIN CARE COMPOSITION COMPRISING A COMBINATION OF PEPTIDES | The Procter & Gamble Company (US) | 2023-11-29 | — | — | EP | claimed |
| CN-116744896-A | Skin care compositions comprising combinations of peptides | 宝洁公司 | 2023-09-12 | — | — | CN | claimed |
| WO-2023156072-A1 | COSMETIC COMPOSITION CONTAINING RETINOID, EXTRACT OF CENTELLA ASIATICA AND A DIPEPTIDE | THE BOOTS COMPANY PLC (GB) | 2023-08-24 | — | — | WO | claimed |
| US-20230165774-A1 | Skin Care Composition and Method of Using the Same | PROCTER & GAMBLE (US) | 2023-06-01 | — | — | US | claimed |
| US-11571378-B2 | Skin care composition and method of using the same | THE PROCTER & GAMBLE COMPANY (US) | 2023-02-07 | — | — | US | claimed |
| EP-1879549-B1 | PERSONAL CARE COMPOSITIONS COMPRISING A DIPEPTIDE | PROCTER & GAMBLE (US) | 2018-09-12 | — | — | EP | claimed |
| CN-108348788-A | The barrier patch of foam films and the method for improving skin appearance | 宝洁公司 | 2018-07-31 | — | — | CN | claimed |
| CN-108135786-A | Barrier patches for foamed films and methods of improving the appearance of skin | 宝洁公司 | 2018-06-08 | — | — | CN | claimed |
| CN-108136230-A | Barrier patches for foamed films and methods of improving the appearance of skin | 宝洁公司 | 2018-06-08 | — | — | CN | claimed |
| CN-108135787-A | Barrier patch for foamed film and method of improving skin appearance | 宝洁公司 | 2018-06-08 | — | — | CN | claimed |
| CN-107148261-A | Method of improving the appearance of skin | 宝洁公司 | 2017-09-08 | — | — | CN | claimed |
| CN-107072886-A | Kit for improving the appearance of skin | 宝洁公司 | 2017-08-18 | — | — | CN | claimed |
| CN-105377219-A | Applied films for smoothing wrinkles and skin texture imperfections | PROCTER & GAMBLE | 2016-03-02 | — | — | CN | claimed |
| CN-104321043-A | Methods for smoothing wrinkles and skin texture imperfections | PROCTER & GAMBLE | 2015-01-28 | — | — | CN | claimed |
| CN-104244910-A | Methods for smoothing wrinkles and skin texture imperfections | PROCTER & GAMBLE | 2014-12-24 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11571378-B2 | Skin care composition and method of using the same | CUTA, ACOX1, ACLY | SLC6A5 4682/4885NOD1 2854/4885NMT2 3073/4885 |
| US-20250152494-A1 | COSMETIC COMPOSITION CONTAINING RETINOID, EXTRACT OF CENTELLA ASIATICA AND A DIPEPTIDE | RARA, RARG, RARB | SLC6A5 4666/4885NOD1 4710/4885NMT2 1358/4885 |
| US-11850299-B2 | Skin care composition and method of using the same | CUTA, ACOX1, PPARA | SLC6A5 4776/4885NOD1 2400/4885NMT2 3297/4885 |
| US-20230165774-A1 | Skin Care Composition and Method of Using the Same | CUTA, ACOX1, PPARA | SLC6A5 4776/4885NOD1 2400/4885NMT2 3297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.